Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001869434 | SCV002167088 | pathogenic | not provided | 2024-01-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg1771*) in the CDH23 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CDH23 are known to be pathogenic (PMID: 11138009, 21940737). This variant is present in population databases (rs750027965, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with CDH23-related conditions. ClinVar contains an entry for this variant (Variation ID: 812254). For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV001869434 | SCV002585225 | pathogenic | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002505534 | SCV002808574 | pathogenic | Autosomal recessive nonsyndromic hearing loss 12; Usher syndrome type 1D; Pituitary adenoma 5, multiple types | 2021-07-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001869434 | SCV003837083 | pathogenic | not provided | 2022-08-31 | criteria provided, single submitter | clinical testing | Identified in a family with Usher syndrome type I in published literature (Sharon et al., 2020); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 32037395, 31456290) |
Baylor Genetics | RCV003473540 | SCV004210607 | likely pathogenic | Pituitary adenoma 5, multiple types | 2023-10-03 | criteria provided, single submitter | clinical testing | |
Sharon lab, |
RCV001002923 | SCV001160958 | pathogenic | Usher syndrome type 1 | 2019-06-23 | no assertion criteria provided | research |